JBF Capital’s Neuronetics STIM Stock Holding History

JBF Capital’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Hold	233,166	–	–	0.04%	72
2026 Q1	$338K	Hold	233,166	–	–	0.05%	77
2025 Q4	$322K	Buy	+233,166	New	+$488K	0.05%	59

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JBF Capital's STIM Position: Q2 2026 in Review

JBF Capital held its Neuronetics (STIM) position steady in Q2 2026 at 233,166 shares worth $303K. The position accounts for 0.04% of the portfolio, ranked #72.

JBF Capital first reported a position in STIM in Q4 2025 and has held it in 3 quarters since. The position peaked at $338K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

JBF Capital held 233,166 shares of Neuronetics worth $303K as of Q2 2026.
JBF Capital left its Neuronetics share count unchanged in Q2 2026.
Neuronetics made up 0.04% of JBF Capital's portfolio in Q2 2026, its #72 holding.
JBF Capital first reported a position in Neuronetics in Q4 2025 and has held it in 3 quarters since.
JBF Capital's Neuronetics position peaked at $338K in Q1 2026.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on JBF Capital's 13F filing for Q2 2026, filed 13 Aug 2026.